Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Prothena Corp Public (PRTA) Research & Development (2016 - 2025)

Historic Research & Development for Prothena Corp Public (PRTA) over the last 14 years, with Q3 2025 value amounting to $28.9 million.

  • Prothena Corp Public's Research & Development fell 4294.9% to $28.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $170.4 million, marking a year-over-year decrease of 2723.73%. This contributed to the annual value of $222.5 million for FY2024, which is 88.32% up from last year.
  • According to the latest figures from Q3 2025, Prothena Corp Public's Research & Development is $28.9 million, which was down 4294.9% from $40.5 million recorded in Q2 2025.
  • In the past 5 years, Prothena Corp Public's Research & Development registered a high of $64.1 million during Q1 2024, and its lowest value of $18.0 million during Q3 2021.
  • Over the past 5 years, Prothena Corp Public's median Research & Development value was $40.5 million (recorded in 2025), while the average stood at $41.1 million.
  • Per our database at Business Quant, Prothena Corp Public's Research & Development surged by 12154.29% in 2022 and then plummeted by 4294.9% in 2025.
  • Over the past 5 years, Prothena Corp Public's Research & Development (Quarter) stood at $22.1 million in 2021, then soared by 67.15% to $36.9 million in 2022, then surged by 67.86% to $61.9 million in 2023, then fell by 18.93% to $50.2 million in 2024, then plummeted by 42.32% to $28.9 million in 2025.
  • Its last three reported values are $28.9 million in Q3 2025, $40.5 million for Q2 2025, and $50.8 million during Q1 2025.